Skip to main content
Chase Science Co.,Ltd logo

Chase Science Co.,Ltd — Investor Relations & Filings

Ticker · 300941 ISIN · CNE100004CZ0 Shenzhen Stock Exchange Manufacturing
Filings indexed 514 across all filing types
Latest filing 2023-01-18 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300941

About Chase Science Co.,Ltd

https://www.echase.cn

Chase Science Co., Ltd. specializes in the research, development, manufacturing, and distribution of medical puncture instruments and laboratory consumables. The company's core product portfolio includes a wide range of medical devices such as safety syringes, insulin syringes, hypodermic needles, and infusion sets designed for clinical use. Additionally, the firm produces specialized veterinary medical instruments and laboratory plasticware. Chase Science emphasizes the integration of safety-engineered technologies into its products to minimize needle-stick injuries and enhance patient care. With a focus on high-precision manufacturing and international quality standards, the company serves a global market, providing essential medical supplies to healthcare facilities and research institutions. Its operations are characterized by a commitment to technological innovation in the field of medical consumables and puncture technology.

Recent filings

Filing Released Lang Actions
独立董事关于第七届董事会第十次会议相关事项的独立意见
Transaction in Own Shares Classification · 95% confidence The document is an independent director's opinion on the company's share repurchase plan, referencing compliance with laws and regulations and the board meeting's approval process. It discusses the share buyback's rationale, funding source, and impact on the company and shareholders. This is a formal statement related to a share repurchase transaction rather than a full report or announcement of voting results. The content fits the category of a Transaction in Own Shares (POS) report, which covers company buyback activities. The document length is short and focused on the share repurchase plan, not a broader financial or management report.
2023-01-18 Chinese
第七届董事会第十次会议决议公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement of a board meeting resolution regarding a share repurchase plan. It includes specifics about the purpose, conditions, price range, quantity, funding source, implementation period, and authorization related to the share buyback. The document is not a financial report or earnings release but a formal announcement of a capital action by the board. It fits the definition of a Transaction in Own Shares (POS) filing, which covers company buyback or sale of its own shares. The document length is 3226 characters, which is sufficient for a full announcement rather than a brief notice. There is no indication that this is a report publication announcement or a regulatory filing fallback. Therefore, the correct classification is POS with high confidence.
2023-01-18 Chinese
关于收到中标通知书的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Fujian Chuangshi Technology Co., Ltd. regarding the receipt of bid award notifications for two marketing service projects from Agricultural Bank of China. It details the bid projects, service terms, and potential impact on the company. The document is short (2016 characters) and serves as an announcement of winning bids rather than a financial report or detailed management discussion. There is no financial data, no regulatory certification, no voting results, no management changes, or other report types. It is a typical capital/financing update related to new contracts and business development. Therefore, the best fitting category is Capital/Financing Update (CAP).
2023-01-10 Chinese
关于拟中标项目的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Fujian Chuangshi Technology Co., Ltd. regarding its status as the leading candidate for winning two marketing service projects from Agricultural Bank of China. It details the project scope, bidding process, service fees, and potential impact on the company. The document is a notification about a potential contract award and does not contain financial statements, audit results, or detailed financial performance data. It is not a report, earnings release, or regulatory filing about financial results. The document is an announcement of a capital or business update related to project awards and contracts, which fits best under Capital/Financing Update (CAP) as it relates to new business opportunities and potential revenue streams. The document length is short (2291 characters), and it is not a report publication announcement or certification. Therefore, the best classification is CAP with high confidence.
2023-01-10 Chinese
关于公司部分董事、高级管理人员减持计划预披露公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding the planned reduction of shareholdings by certain company directors and senior management personnel. It details the shareholders involved, the number and percentage of shares to be reduced, the reasons for reduction, the methods and timing of the reduction, and compliance with regulatory requirements. It includes commitments made by the shareholders and risk warnings related to the share reduction plan. The document does not contain financial statements or performance data, nor is it a report or presentation. It is a formal disclosure of insider share transactions by company directors and executives. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 3602 characters, which is consistent with a detailed announcement but not a full report.
2022-11-29 Chinese
2022年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '福建创识科技股份有限公司2022 年第三季度报告' which translates to 'Fujian Chuangshi Technology Co., Ltd. 2022 Third Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on non-recurring gains and losses. The document explicitly states it is a quarterly report for the third quarter of 2022 and mentions that it is unaudited. The length of the document (over 10,000 characters) and the presence of comprehensive financial statements confirm it is a substantive financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2022-10-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.